phs000007.v30.p11 Framingham Cohort | Versions 1-30: passed embargo
| VDAS | 15154 | Longitudinal | | HuGeneFocused50K_Affy Mapping250K_Nsp Mapping250K_Sty Mapping50K_Hind240 Mapping50K_Xba240
|
phs000280.v5.p1 Atherosclerosis Risk in Communities (ARIC) Cohort | Versions 1-5: passed embargo
| VDAS | 15678 | Longitudinal, Cohort | | |
phs001645.v1.p1 Genomic Landscape of Cutaneous Diffuse Large B Cell Lymphoma | Version 1: passed embargo
| VDAS | 25 | Case Set | Links | xGen Exome Research Panel v1.0 SureSelect Human All Exon V5 50Mb plus UTRs
|
phs000573.v1.p1 Genetic Heterogeneity of Diffuse Large B Cell Lymphoma | Version 1: passed embargo
| VDAS | 94 | Case-Control | Links | HiSeq 2500 Human Gene ST1.0
|
phs001526.v1.p1 Next Generation Sequencing of Diffuse Intrinsic Pontine Glioma Samples | Version 1: passed embargo
| VDAS | 14 | Sequencing, Cohort | Links | HiSeq TruSeq ABI Prism Genetic Analyser 3100
|
phs000450.v3.p1 Whole Exome Sequencing of Diffuse Large B-Cell Lymphoma | Versions 1-3: passed embargo
| VDAS | 306 | Case Set, Tumor | | Agilent selected, 76bp paired end reads HiSeq 2500
|
phs001444.v2.p1 Genomic Variation in Diffuse Large B Cell Lymphomas | Version 1: Version 2:
| VDAS | 489 | Case Set | Links | |
phs000090.v4.p1 GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study | Versions 1-4: passed embargo
| VDAS | 12771 | Case-Control | | AFFY_6.0
|
phs000086.v3.p1 DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes | Versions 1-3: passed embargo
| VDAS | 1497 | Clinical Trial, Longitudinal | Links | HumanHap550v3.0 ILLUMINA_Human_1M
|
phs001538.v1.p1 NAMDC Patient Registry and Biorepository | Version 1: passed embargo
| VDAS | 541 | Methods Development | Links | |
phs001516.v1.p1 Phenotype Risk Score Study of Rare Variants | Version 1: passed embargo
| VDAS | 21701 | Cohort | Links | Infinium HumanExome BeadChip
|
phs000614.v1.p1 Genomic Analysis of Pediatric Low Grade Gliomas | Version 1: passed embargo
| VDAS | 1 | Case Set | Links | HiSeq 2000
|
phs000889.v1.p1 NCI Non-Hodgkin Lymphoma GWAS: DLBCL | Version 1: passed embargo
| VDAS | 2661 | Case-Control, Case Set, Cohort | Links | HumanOmniExpress
|
phs001184.v2.p2 CTSP Diffuse Large B-Cell Lymphoma (DLBCL) CALGB 50303 | Versions 1-2: passed embargo
| VDAS | | Case Set | Links | HiSeq 2500 HiSeq 2500
|
phs001175.v2.p2 CTSP: Clinical Trial Sequencing Project | Versions 1-2: passed embargo
| VDAS | 366 | Case Set | Links | |
phs000287.v6.p1 Cardiovascular Health Study (CHS) Cohort | Versions 1-6: passed embargo
| VDAS | 5609 | Longitudinal | | |
phs000942.v1.p1 Use of WGS for Diagnosis and Discovery in the Cancer Genetics Clinic | Version 1: passed embargo
| VDAS | 258 | Cohort | Links | Assembler Version 2.4.0.43
|
phs000900.v1.p1 Functionally-defined Therapeutic Targets in DIPG | Version 1: passed embargo
| VDAS | 22 | Cohort | Links | SureSelect Human All Exon v4+UTRs SureSelect Human All Exon v3 - 50Mb TruSeq RNA Sample Preparation Kit HiSeq 2000
|
phs000328.v2.p1 Genome-wide Analysis of Lymphoma | Versions 1-2: passed embargo
| VDAS | 119 | Tumor vs. Matched-Normal, Case-Control | | 454 GS FLX Titanium AFFY_6.0 High Density 2.1M Human Exome Array SureSelect Human All Exon 51Mb Target Enrichment Kit HiSeq 2000
|
phs000605.v1.p1 Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus Trial (The MILES Trial) | Version 1: passed embargo
| VDAS | 111 | Clinical Trial, Clinical Diagnostic Testing, Randomized Controlled Clinical Trial | Links | |